Furthermore, in a sub-group of NR AML blast samples (Figure 3, red squares in the lower left hand quadrant) low level signaling responses in both Jak/Stat and PI3K pathways were seen, suggesting that other pathways could be contributing to clinical refractoriness to chemotherapy. Here, PIK3CD is linked to acute myeloid leukemia.